news

Health Commission Advisors will discuss Advertising Regulations for Over-The-Counter Medicines in Argentina

The advisers of the Commission of Systems, Media and Freedom of Expression from the Argentine Senate, chaired by Alfredo Luenzo (Somos Todos - opposition) debated a bill on the advertising of OTC medicines, an initiative presented by the opposition senator Daniel Lovera (La Pampa). The commission advisors began studying the text in August. On that occasion, they agreed with the...

COFEPRIS announces the revocation of advertising criteria and guidelines

In accordance with article 4 of the Federal Law of Administrative Procedure and article 71 of the General Law of Regulatory Improvement, the guidelines and criteria regarding: attention for the procedure of advertising of non-prescription medicines (OTCs), homeopathic and herbal remedies, the promotion of healthy habits, advertising permits for alcoholic beverages, and administrative simplification for digital advertising procedures, show...

Medicines II Bill

Currently, a set of amendments to the Health Code known as the Medicnes II Bill by the Executive, is in legislative process. While there are positive proposals that tend to reduce the price of medicines, such as allowing the sale of OTC medicines in commercial establishments, there are also other very harmful ones, such as establishing price fixations, banning of...

ANVISA opens public consultation to update the list of over-the-counter medications

On September, ANVISA published in the Journal of the Union the public consultation to update the list of over-the-counter medicines. Interested in participating may do so from October 2, until November 18. The regulations put into consultation define the list of medicines classified by Anvisa as exempt from prescription (MIPs for its acronym in Portuguese), for synthetic and biological...

ILAR OTC Group Event – CDMX 2019

On July 24th and 25th, ILAR's OTC Group Meeting took place in Mexico City during the International Self-Care Week. Representatives of the Regulatory Agencies and National Association from Argentina, Brazil, Colombia and Mexico as well as experts and the private sector gathered to discuss relevant aspects in terms of regulatory harmonization, research and tools for collecting factual information and trends...

ILAR in Washington DC at the 57th Meeting of the Directing Council of the Pan American Health Organization (PAHO)

ILAR’s Director General Juan Thompson attended the 57th meeting of the Directing Council of the Pan American Health Organization in Washington DC. From September 30th to October 4th, the event brought together Ministers of Health and other high-level delegates from the Americas to discuss health priorities and action plans. A new PAHO Strategic Plan 2020-2025 was launched during the meeting, which...

Estudio Revela El Impacto Social Y Económico De Promover El Autocuidado De La Salud En Latinoamérica

La Asociación Regional de Medicamentos de Venta Libre en Latinoamérica, ILAR, presentó los resultados de una investigación que estima los beneficios del uso responsable de medicamentos de venta libre (OTC), en los sistemas nacionales de salud pública. El estudio se enfocó en las enfermedades comunes y de mayor impacto en la región, como el resfriado común, la diarrea...

ILAR presente en el evento de la Asociación Mexicana de Medicamentos de Libre Acesso (AFAMELA)

El Director General de ILAR, Juan Thompson, participó el pasado 17 de abril del evento “El autocuidado como herramienta para fortalecer el sistema de salud y el bienestar de los mexicanos”, organizado por la Asociación de Medicamentos de Libre Acesso, AFAMELA, en la Ciudad de Mexico. El evento contó con la participación del Comisionado Federal de COFEPRIS, el Lic. Julio...

Participación de ILAR en la III Conferencia Latinoamericana de Nicholas Hall sobre OTCs

Los dias 8 y 9 de Noviembre, el Director General de ILAR Juan Thompson participó de la III Conferencia de Nicholas Hall en América Latina sobre OTC. La conferencia contó con la participación de varios referentes en materia de Medicamentos sin Prescripción en América Latina, así como también con participantes internacionales quienes mostraron las tendencias en dicha categoria de...

Reunión del Grupo OTC de ILAR en Washington DC

Los dias 4 y 5 de diciembre 2017, ILAR celebró la Reunión del Grupo OTC con funcionarios de ANMAT (Argentina), COFEPRIS (México) e INVIMA (Colombia) en la ciudad de Washington DC. Entre los principales temas discutidos se destaca el del Valor Económico del Auto-Cuidado. Representantes de ILAR y la Asociación Mexicana de Fabricantes de Medicamentos de Libre Acceso (AFAMELA), presentaron...